Andrea Antinori to Cyclohexanes
This is a "connection" page, showing publications Andrea Antinori has written about Cyclohexanes.
Connection Strength
0.175
-
Switch to maraviroc with darunavir/r, both QD, in patients with suppressed HIV-1 was well tolerated but virologically inferior to standard antiretroviral therapy: 48-week results of a randomized trial. PLoS One. 2017; 12(11):e0187393.
Score: 0.175